Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04824053 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of UNICLA-A2 Dairy Products on Patients at High-risk of Colorectal Cancer Development

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Nov 30, 2025 to Nov 30, 2027
    • Study completion date: Dec 15, 2026 to Dec 15, 2028
    v7
  2. Primary completion date: May 30, 2025 to Nov 30, 2025
    • Study completion date: Feb 15, 2026 to Dec 15, 2026
    • Eligibility criteria expanded, about 13 words
    • Site details revised
    v6
  3. Primary completion date: Dec 30, 2023 to May 30, 2025
    • Study completion date: Dec 15, 2024 to Feb 15, 2026
    • Collaborators revised (2)
    v5
  4. Start date changed from estimate of Sep 1, 2022 to Feb 28, 2022v4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Nov 1, 2021 to Sep 1, 2022
    • Site details revised
    v3
  6. Start date: Apr 5, 2021 to Nov 1, 2021v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Dietary intervention with UNICLA-A2 milk products containing beta casein A2 protein, and higher levels of omega-3 fatty acids and selenium may contribute to maintain the intestinal integrity, reduce inflammatory processes, normalize the immune system, protect against oxidative damage and equilibrate the gut microbiota in high-risk colorectal cancer patients who have undergone polypectomy
Trial Details
NCT Number NCT04824053
Lead Sponsor Instituto de Investigación Sanitaria Aragón
Collaborators: Cooperativas Lacteas Unidas, Hospital Clínico Universitario Lozano Blesa
Conditions
(from sponsor)		 Colorectal Polyp
Related terms Inflammation, Polyps
Enrollment 34 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov